Elevated p53 and p21waf1 mRNA expression in blood lymphocytes from lung cancer patients with chemoresistance

Chuen Ming Shih, Kwunmin Chen, Yu Chieh Wang, Pei Jung Lee, Yi Ching Wang

研究成果: 雜誌貢獻期刊論文同行評審

4 引文 斯高帕斯(Scopus)


Background: Clinical and experimental studies suggest that alteration of the expression level of the p53 gene and other damage responsive genes may be associated with chemoresistance in cancer patients. Methods: The present study evaluated the differences of the basal levels of lymphocytic p53 and p21waf1 mRNA expression collected before receiving cisplatin-based chemotherapy between 48 chemo-ineffective lung cancer patients and 39 chemo-effective lung cancer patients using an optimized semi-quantitative multiplex reverse transcriptase-polymerase chain reaction (RT-PCR). Results: The data indicated that the mean mRNA level of p53 gene in chemo-ineffective patients (0.66) was 26.9% higher than that of the chemo-effective patients (0.52) with statistical significance (P = 0.03), and a significantly higher level of p21waf1 mRNA expression in the chemo-ineffective patients (P = 0.03) was also observed. In addition, by the multiplex long quantitative PCR analysis, we demonstrated that chemo-ineffective and chemo-effective patients have similar amounts of UV damage on their p53 gene of lymphocyte DNA through equal UV treatment. Conclusion: Our results suggest that elevated levels of p53/p21waf1 mRNA in blood lymphocytes collected before chemotherapy may predict the chemoresponses of lung cancer patients.

頁(從 - 到)366-370
期刊Cancer Detection and Prevention
出版狀態已發佈 - 2007

ASJC Scopus subject areas

  • 腫瘤科
  • 癌症研究


深入研究「Elevated p53 and p21waf1 mRNA expression in blood lymphocytes from lung cancer patients with chemoresistance」主題。共同形成了獨特的指紋。